J-Beauty and C-Beauty: Shiseido, Kao, Florasis Abroad — 2026-10-03
Japanese cosmetics giants are rebounding on inbound tourism and structural reforms, while Chinese beauty brands accelerate their global expansion into Japan and Southeast Asia with offline retail strategies. Shiseido's first-half profit jumped 90%, Kao hit record earnings, and Chinese brands like Florasis now target brick-and-mortar presence across Asia and beyond.
J-Beauty and C-Beauty: Shiseido, Kao, Florasis Abroad — 2026-10-03
Top developments
Shiseido Posts 90% Core Profit Jump on Restructuring and Inbound Recovery
Shiseido's H1 2026 core operating profit surged 90.1% year-over-year to ¥444.3 billion, with sales up 6.2% to ¥498.9 billion, driven by structural reform payoffs and recovering Japanese inbound tourism. The company expects full-year net sales of ¥990 billion (+2.1% YoY) and core operating profit growth of 55%, signaling sustained momentum after two consecutive years of net losses through 2025.
Kao Reaches Record Operating Profit as Restructuring Pays Off
Kao reported record operating profit in its H1 2026 results, with cosmetics and chemical segments leading growth. The company's high-value-product strategy and operational restructuring are delivering sustained earnings improvement, positioning Kao as a stability counterweight to Shiseido's more volatile turnaround.
Inbound Tourism Fueling Japanese Prestige Beauty Renaissance
Japanese inbound visitor arrivals exceeded 36 million in 2025, with Chinese visa relaxation triggering 20–30% YoY sales growth in prestige brands like Clé de Peau Beauté, SK-II, and Cosme Decorté at department stores. Makeup demand has fully recovered from the mask-wearing era, creating a three-pronged growth tailwind: defensive consumer staples, inbound tourism, and renewed Chinese market appetite for Japanese brands.
Florasis Claims 40% of Overseas Revenue from Japan; Expands Sephora Footprint
Florasis, China's leading floral-herbal cosmetics brand, saw Japan account for 40% of its total overseas sales, reflecting strong consumer preference for flower- and herbal-medicine-based formulations. The brand has secured placement in 210 Sephora outlets globally, supported by offline advisors and regional campaigns to shift from online-only to omnichannel distribution.
C-Beauty Brands Move Beyond Cross-Border E-Commerce into Flagship Retail
Chinese beauty brands including Perfect Diary, Flower Knows, Proya, and Judydoll are no longer relying solely on Tmall and Shopee; they are opening flagship stores in Tokyo's Ginza, entering Sephora and Ulta Beauty, and building regional hubs in Southeast Asia. This pivot from livestream-led e-commerce to physical retail marks a maturation of the guochao wave, signaling confidence in sustained brand equity and consumer loyalty beyond flash sales. and
Local view
Japanese business press (業界マップ, 週刊粧業) emphasizes that the cosmetics sector's "three axes"—defensive characteristics, inbound recovery, and Chinese market re-engagement—are reshaping equity valuations. Investors are reassessing Shiseido, Kao, and Kosé as long-term value plays as structural headwinds ease and tourism rebounds.
Chinese financial media (凤凰财经, 知乎) report that leading brands like Peroleya (珀莱雅) have posted 30% YoY revenue growth and are now prioritizing overseas H-stock listings and Southeast Asia expansion to diversify away from domestic saturation. The narrative has shifted from "can we go global?" to "which markets will drive the next decade of growth?"
Context & numbers
- Shiseido H1 2026: Sales ¥498.9B (+6.2% YoY); core operating profit ¥444.3B (+90.1% YoY); full-year guidance: ¥990B revenue, +55% core profit growth.
- Japan inbound tourism: 36+ million visitors in 2025; prestige brand sales at department stores up 20–30% YoY due to Chinese visa easing.
- Florasis Japan revenue: 40% of total overseas sales in 2025; 210 Sephora locations globally secured.
- Chinese cosmetics market: Rebounded ~5% from 2024 to 2025 after years of contraction; guochao brands now rank top-three on Tmall and Douyin.
On the radar
- Cosmoprof Asia 2026 (November, Shanghai & Hong Kong): Likely venue for C-beauty brands to announce U.S. and European retail partnerships.
- Shiseido China joint venture exit: Beijing Liyuan seeking to sell its 35% stake in Shiseido Liyuan Cosmetics, ending a three-decade partnership—potential signal of strategic shift or valuation pressure in mainland China operations.
- Kao and Kosé earnings updates due Q4 2026: Watch for inbound tourism impact on prestige segment and competitive positioning versus Shiseido's structural gains.
- Peroleya H-stock listing momentum: Brand's 30% YoY growth and overseas focus may trigger IPO or acquisition rumors by global beauty conglomerates seeking C-beauty exposure.
Note on freshness: This article covers developments published between 2026-09-26 and 2026-10-03. Older content on C-beauty global ambitions (from mid-2026 and earlier) and Shiseido's restructuring roadmap (from early 2026) has been excluded per editorial guidelines, though it provides important context for the recent earnings surge and retail expansion narratives cited above.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
